We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-11.87%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$221B
AUM Growth
-$31.8B
Cap. Flow
+$2.77B
Cap. Flow %
1.26%
Top 10 Hldgs %
15.08%
Holding
8,767
New
731
Increased
3,710
Reduced
3,260
Closed
648

Sector Composition

Rank Sector Weight
1 Technology 8.03%
2 Financials 6.64%
3 Healthcare 6.26%
4 Consumer Discretionary 5.11%
5 Industrials 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITRM
7826
DELISTED
Iterum Therapeutics
ITRM
$1K ﹤0.01%
+9
New +$852
JMOM icon
7827
JPMorgan US Momentum Factor ETF
JMOM
$2.48B
$1K ﹤0.01%
40
-119
-75% -$3.05K
JVA icon
7828
Coffee Holding Co
JVA
$19.5M
$1K ﹤0.01%
281
-1,494
-84% -$6.25K
KNDI
7829
Kandi Technologies Group
KNDI
$67.5M
$1K ﹤0.01%
400
KTCC icon
7830
Key Tronic
KTCC
$42.8M
$1K ﹤0.01%
+143
New +$982
LINC icon
7831
Lincoln Educational Services
LINC
$1.33B
$1K ﹤0.01%
409
-4,837
-92% -$11.4K
MARA icon
7832
Marathon Digital Holdings
MARA
$4.32B
$1K ﹤0.01%
511
-4,793
-90% -$11.5K
MATH icon
7833
Metalpha Technology Holding
MATH
$44.8M
$1K ﹤0.01%
980
+74
+8% +$130
MBRX icon
7834
Moleculin Biotech
MBRX
$2.83M
-2
Closed -$5.74K
NGNE icon
7835
Neurogene
NGNE
$656M
$1K ﹤0.01%
19
OGEN icon
7836
Oragenics
OGEN
$2.26M
$1K ﹤0.01%
+1
New +$1.96K
ONCY
7837
Oncolytics Biotech
ONCY
$89.9M
$1K ﹤0.01%
812
-5,241
-87% -$14.2K
OTLK icon
7838
Outlook Therapeutics
OTLK
$183M
$1K ﹤0.01%
9
-42
-82% -$5.17K
OXBR icon
7839
Oxbridge Re Holdings
OXBR
$10.6M
$1K ﹤0.01%
878
-2,865
-77% -$3.03K
PEX icon
7840
ProShares Global Listed Private Equity ETF
PEX
$11.5M
$1K ﹤0.01%
30
-598
-95% -$19.7K
JF
7841
J and Friends Holdings
JF
$16.8M
$1K ﹤0.01%
+25
New +$1.4K
QARP icon
7842
Xtrackers Russell 1000 US Quality at a Reasonable Price ETF
QARP
$76.4M
$1K ﹤0.01%
54
-1,945
-97% -$49.5K
QRHC icon
7843
Quest Resource Holding
QRHC
$26.8M
$1K ﹤0.01%
1,118
-3,733
-77% -$7.18K
QUAD icon
7844
Quad
QUAD
$536M
$1K ﹤0.01%
100
-203,951
-100% -$3.29M
RAAX icon
7845
VanEck Inflation Allocation ETF
RAAX
$1.12B
$1K ﹤0.01%
+60
New +$1.49K
RGLS
7846
DELISTED
Regulus Therapeutics
RGLS
$1K ﹤0.01%
94
-40
-30% -$662
SMMT icon
7847
Summit Therapeutics
SMMT
$10.4B
$1K ﹤0.01%
1,139
+682
+149% +$1.06K
TROO icon
7848
TROOPS Inc
TROO
$208M
$1K ﹤0.01%
965
-30
-3% -$29
UAE icon
7849
iShares MSCI UAE ETF
UAE
$308M
$1K ﹤0.01%
+49
New +$719
VRNA
7850
DELISTED
Verona Pharma
VRNA
$1K ﹤0.01%
+138
New +$1.57K

Similar funds

UBS Group's Q4 2018 Portfolio in Review

As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group's Q4 2018 filing shows 731 new, 3,710 increased, 3,260 reduced and 648 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.3% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
  • UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
  • UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
  • UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
  • UBS Group opened 731 new positions and closed 648 in Q4 2018.
  • UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.